| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.7 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.7 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |